3 x 14 mg/m2 idarubicin during induction: results of a pilot study in children with AML.
Creutzig U, Körholz D, Niemeyer CM, Kabisch K, Graf N, Reiter A, Scheel-Walter H, Bender-Götze C, Behnisch W, Hermann J, Mann G, Ritter J, Zimmermann M.
Creutzig U, et al. Among authors: kabisch k.
Leukemia. 2000 Feb;14(2):340-2. doi: 10.1038/sj.leu.2401670.
Leukemia. 2000.
PMID: 10673757
No abstract available.